- Recent Funding
- Investors
- Healthworx
Healthworx portfolio
Healthworx has 3 portfolio companies on record at Recent Funding.
About this page
Its most recent investment on record is ShiftMed's $45M Series B+ round in October 2021, alongside Motley Fool Ventures, BIP Ventures, 3TS Capital Partners and 1 other. By category, its portfolio leans toward Health and bio (3) and Consumer and social (2).
What Healthworx invests in
- Health and bio · 3 · 100%
- Consumer and social · 2 · 67%
- Developer tools and cloud · 1 · 33%
- HR and recruiting · 1 · 33%
How Healthworx invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $45M |
Healthworx portfolio companies
SShiftMed$45MSeries B+ · Oct 2021
CChamber Cardiobacker
FFlowlybacker
| Company | Round with Healthworx | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $45M | $245M | Feb 6, 2023 round |
Health and bio |
backer | $8M | Feb 4, 2026 Series A |
Health and bio |
backer | undisclosed | — |
Most frequent co-investors
MMotley Fool Ventures1 shared round · last Oct 27, 2021
33TS Capital Partners1 shared round · last Oct 27, 2021
BBlue Heron Capital1 shared round · last Oct 27, 2021
BBIP Ventures1 shared round · last Oct 27, 2021
Similar investors
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Healthworx. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Healthworx, which is a subset of its real portfolio. API: /api/v1/investors/healthworx (get a free API key). More: the most active VC firms and new venture capital funds.